SIBO has an effect on the structural and functional characteristics of the liver, resulting in higher insulin and glucose levels, higher neutrophil-to-lymphocyte ratios, and a greater prevalence of NAFLD. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.